InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by MacLean Michael F, 首席财务官. Insider active across 1 company, notably Avidity Biosciences, Inc.. Cumulatively, 17 disclosures have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €3.2m. History available since 20 January 2023. The latest transaction was filed on 21 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to MacLean Michael F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
133,977 股Common StockSEC:0001193125-26-082300:0
1,807 股@ US$72.452.3% 占其流量Common StockSEC:0001599901-26-000023:0
1,974 股@ US$72.232.5% 占其流量Common StockSEC:0001599901-26-000010:0
30,914 股@ US$42.72640.50% mcap50.0% 占其流量Common StockSEC:0001599901-25-000161:0
7,935 股@ US$31.05543.9% 占其流量Common StockSEC:0001599901-25-000069:0
1,622 股@ US$28.59290.8% 占其流量Common StockSEC:0001599901-25-000041:0
25,000 股0Common StockSEC:0001599901-25-000023:0
11,151 股@ US$32.665.9% 占其流量Common StockSEC:0001599901-24-000206:0
27,262 股@ US$46.218819.8% 占其流量Common StockSEC:0001599901-24-000188:0
25,000 股0Common StockSEC:0001599901-24-000156:0
25,000 股0Common StockSEC:0001599901-24-000110:0
104,245 股@ US$8.8214.6% 占其流量Common StockSEC:0001599901-24-000101:0
75,000 股@ US$8.8210.5% 占其流量Common StockSEC:0000950170-24-061258:0
40,000 股@ US$8.825.5% 占其流量Common StockSEC:0001599901-24-000044:0
1,616 股@ US$10.130.3% 占其流量Common StockSEC:0001599901-24-000008:1
22,500 股0Common StockSEC:0001599901-24-000008:0
18,500 股0Common StockSEC:0001209191-23-004756:0
17 条申报中的 17 条
About MacLean Michael F
Michael F. MacLean is the Chief Financial Officer of Avidity Biosciences, Inc. In this role, he oversees the financial operations of the company, including financial planning, risk management, and financial reporting. His expertise contributes to the financial health and growth of the company.
